News
JBPHF
0.868
NaN%
--
Weekly Report: what happened at JBPHF last week (0908-0912)?
Weekly Report · 09/15/2025 11:06
Weekly Report: what happened at JBPHF last week (0901-0905)?
Weekly Report · 09/08/2025 11:09
Weekly Report: what happened at JBPHF last week (0825-0829)?
Weekly Report · 09/01/2025 11:04
Jacobio Pharmaceuticals Group reports 1H results
Seeking Alpha · 08/29/2025 20:14
Weekly Report: what happened at JBPHF last week (0818-0822)?
Weekly Report · 08/25/2025 11:14
Weekly Report: what happened at JBPHF last week (0811-0815)?
Weekly Report · 08/18/2025 11:06
Weekly Report: what happened at JBPHF last week (0804-0808)?
Weekly Report · 08/11/2025 11:13
Weekly Report: what happened at JBPHF last week (0728-0801)?
Weekly Report · 08/04/2025 11:16
Weekly Report: what happened at JBPHF last week (0721-0725)?
Weekly Report · 07/28/2025 11:17
Weekly Report: what happened at JBPHF last week (0714-0718)?
Weekly Report · 07/21/2025 11:07
Weekly Report: what happened at JBPHF last week (0707-0711)?
Weekly Report · 07/14/2025 11:16
Weekly Report: what happened at JBPHF last week (0630-0704)?
Weekly Report · 07/07/2025 11:07
Weekly Report: what happened at JBPHF last week (0623-0627)?
Weekly Report · 06/30/2025 11:14
Weekly Report: what happened at JBPHF last week (0616-0620)?
Weekly Report · 06/23/2025 11:06
Weekly Report: what happened at JBPHF last week (0609-0613)?
Weekly Report · 06/16/2025 11:13
More
Webull provides a variety of real-time JBPHF stock news. You can receive the latest news about Jacobio Pharms through multiple platforms. This information may help you make smarter investment decisions.
About JBPHF
Jacobio Pharmaceuticals Group Co Ltd is an investment holding company mainly engaged in the research and development of new drugs at the clinical stage. The Company is primarily responsible for the independent discovery and development of innovative tumor therapies. The Company's main drug development projects include JAB-21822 and JAB-3312 clinical stage allosteric SHP2 inhibitors. The Company mainly operates its businesses in China market.